← 產業報告目錄
Ocular Inflammation Treatment Market Size, Share & Trends Analysis Report By Treatment Type (Corticosteroids, Antibiotics, Monoclonal Antibodies, Immunosppressant, Cycloplegic Agents, Antivirals, Antifungal, Analgesics), By Disease Type, By Mode of Administration, By Distribution Channel, By Region, And By Segment Forecasts, 2024-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-01-26頁數 180報告編號 INSIGHTACE-b3f18e2876
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The Ocular Inflammation Treatment Market on a global scale was estimated at USD 428.7 Mn in 2023 and is anticipated to attain USD 690.4 Mn by 2031, with a projected CAGR of 6.31% between 2024 and 2031.
Ocular Inflammation Treatment covers reshaping how healthcare entities approach this space.
The market's upward path is underpinned by surging healthcare spending, technological evolution, and the surging focus on personalized and precision-based approaches in healthcare.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, underpinned by rapid industrialization and expanding end-user bases.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Ocular Inflammation Treatment Market Snapshot
Chapter 4. Global Ocular Inflammation Treatment Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Treatment Type Estimates & Trend Analysis
5.1. by Treatment Type & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Treatment Type:
5.2.1. Corticosteroids
5.2.2. Antibiotics
5.2.3. Monoclonal Antibodies
5.2.4. Immunosppressant
5.2.5. Cycloplegic Agents
5.2.6. Antivirals
5.2.7. Antifungal
5.2.8. Analgesics
Chapter 6. Market Segmentation 2: by Disease Type Estimates & Trend Analysis
6.1. by Disease Type & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Disease Type:
6.2.1. Anterior Uveitis
6.2.2. Posterior Uveitis
6.2.3. Pan Uveitis
6.2.4. Intermediate Uveitis
6.2.5. Episcleritis/Scleritis
Chapter 7. Market Segmentation 3: by Mode of Administration Estimates & Trend Analysis
7.1. by Mode of Administration & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Mode of Administration:
7.2.1. Topical
7.2.2. Injectable
7.2.3. Oral
7.2.4. Others
Chapter 8. Market Segmentation 4: by Distribution Channel Estimates & Trend Analysis
8.1. by Distribution Channel & Market Share, 2019 & 2031
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Distribution Channel:
8.2.1. Hospital Pharmacies
8.2.2. Retail Pharmacies
8.2.3. Online Pharmacies
8.2.4. Drug Stores
Chapter 9. Ocular Inflammation Treatment Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Ocular Inflammation Treatment Market Revenue (US$ Million) Estimates and Forecasts by Treatment Type, 2023-2031
9.1.2. North America Ocular Inflammation Treatment Market Revenue (US$ Million) Estimates and Forecasts by Disease Type, 2023-2031
9.1.3. North America Ocular Inflammation Treatment Market Revenue (US$ Million) Estimates and Forecasts by Mode of Administration, 2023-2031
9.1.4. North America Ocular Inflammation Treatment Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2023-2031
9.1.5. North America Ocular Inflammation Treatment Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
9.2. Europe
9.2.1. Europe Ocular Inflammation Treatment Market Revenue (US$ Million) Estimates and Forecasts by Treatment Type, 2023-2031
9.2.2. Europe Ocular Inflammation Treatment Market Revenue (US$ Million) Estimates and Forecasts by Disease Type, 2023-2031
9.2.3. Europe Ocular Inflammation Treatment Market Revenue (US$ Million) Estimates and Forecasts by Mode of Administration, 2023-2031
9.2.4. Europe Ocular Inflammation Treatment Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2023-2031
9.2.5. Europe Ocular Inflammation Treatment Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
9.3. Asia Pacific
9.3.1. Asia Pacific Ocular Inflammation Treatment Market Revenue (US$ Million) Estimates and Forecasts by Treatment Type, 2023-2031
9.3.2. Asia Pacific Ocular Inflammation Treatment Market Revenue (US$ Million) Estimates and Forecasts by Disease Type, 2023-2031
9.3.3. Asia-Pacific Ocular Inflammation Treatment Market Revenue (US$ Million) Estimates and Forecasts by Mode of Administration, 2023-2031
9.3.4. Asia-Pacific Ocular Inflammation Treatment Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2023-2031
9.3.5. Asia Pacific Ocular Inflammation Treatment Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
9.4. Latin America
9.4.1. Latin America Ocular Inflammation Treatment Market Revenue (US$ Million) Estimates and Forecasts by Treatment Type, 2023-2031
9.4.2. Latin America Ocular Inflammation Treatment Market Revenue (US$ Million) Estimates and Forecasts by Disease Type, 2023-2031
9.4.3. Latin America Ocular Inflammation Treatment Market Revenue (US$ Million) Estimates and Forecasts by Mode of Administration, 2023-2031
9.4.4. Latin America Ocular Inflammation Treatment Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2023-2031
9.4.5. Latin America Ocular Inflammation Treatment Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
9.5. Middle East & Africa
9.5.1. Middle East & Africa Ocular Inflammation Treatment Market Revenue (US$ Million) Estimates and Forecasts by Treatment Type, 2023-2031
9.5.2. Middle East & Africa Ocular Inflammation Treatment Market Revenue (US$ Million) Estimates and Forecasts by Disease Type, 2023-2031
9.5.3. Middle East & Africa Ocular Inflammation Treatment Market Revenue (US$ Million) Estimates and Forecasts by Mode of Administration, 2023-2031
9.5.4. Middle East & Africa Ocular Inflammation Treatment Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2023-2031
9.5.5. Middle East & Africa Ocular Inflammation Treatment Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Bausch Health Companies, Inc.
10.2.2. Pfizer Inc.
10.2.3. Novartis AG
10.2.4. AbbVie, Inc.
10.2.5. Cipla Inc.
10.2.6. EyeGate
10.2.7. Alimera Sciences
10.2.8. EyePoint Pharmaceuticals, Inc.
10.2.9. Ocular Therapeutix, Inc.
10.2.10. Santen Pharmaceutical Co., Ltd.
10.2.11. Akron Pharma Inc
10.2.12. Sanofi S.A.
10.2.13. GlaxoSmithKline plc
10.2.14. Intas Pharmaceuticals Ltd
10.2.15. Johnson & Johnson Services Inc.
10.2.16. Macleods Pharmaceuticals Ltd.
10.2.17. Merck & Co. Inc.
10.2.18. Tarsier Pharma
10.2.19. Other Prominent Players
10.2.20. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們